Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-05-02
2006-05-02
Priebe, Scott D. (Department: 1633)
Chemistry: molecular biology and microbiology
Vector, per se
C435S325000, C435S456000, C424S093200, C536S023100, C536S023720
Reexamination Certificate
active
07037712
ABSTRACT:
A genome of an ovine adenovirus designated OAV287 is isolated from sheep and sequenced. Portions of the genome not essential for maintenance or viability of the virus can be deleted or altered. A nucleotide sequence encoding a non-adenoviral polypeptide can be incorporated into the genome. The a full-length clone of the genome can be provided as part of a plasmid or viral vector. Cells can be transformed with a vector of the invention such that they express an exogenous protein.
REFERENCES:
patent: 6020172 (2000-02-01), Both
Adair et al.: “Serological Identification of an Australian Adenovirus Isolate From Sheep”, Australian Veterinary Journal, vol. 63, No. 5, 1986, p. 162.
Elgadi et al.: “Sequence and Sequence Analysis of E1 and pIX Regions of the BAV3 Genome”, INTERVIROLOGY, vol. 36, 1993, pp. 113-120.
Shibata et al.: Nucleotide Sequence of E1 Region of Canine Adenovirus Type 2, VIROLOGY, vol. 172, 1989, pp. 460-467.
Salmon et al.: “Subcloning and Restriction Mapping of Bovine Adenovirus Type 2”, INTERVIROLOGY, vol. 36, No. 2, 1993, pp. 72-78.
Vrati et al.: “Sequence of Ovine Adenovirus Homologs for 100K Hexon Assembly, 33K, pVIII, and Fiber Genes: Early Retion E3 is not in the expected Location”, VIROLOGY, vol. 209, Jun. 1, 1995, pp. 400-408.
“Oligonucleotide probes for the screening of recombinant DNA libraries”, by Wallace et al., Methods Enzymol. vol. 152, p. 432-442.
“Computational complexity, protein structure prediction, and the Levinthal paradox”, by Ngo et al., The Protein Folding Problem and Tertiary Structure Prediction, Birkhouser Boston: Boston, MA, pp. 433 and 492-595.
Sambrook et al., Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 11-47.
“Report and recommendations of the panel to assess the NIH investment in research on gene therapy”, by Orkin et al., issued by the U.S. National Institute of Health.
“Facilitating oligonucleotide delivery: helping antisense deliver on its promis”, by Gewirtz, et al., Proc. Natl. Acad. Sci. USA, vol. 93, pp. 3161-3163.
“Toward gene-inhibition therapy: a review of progress and prospects in the fields of antiviral antisense nucleic acids and ribozymes”, by James, Anitviral Chem. Chemother. vol. 2, No. 4, pp. 191-214.
“Ribozymes as human therapeutic agents”, by Christofferson, et al., J. Med. Chem. vol. 38, No. 12, pp. 2023-2037.
“Adenovirus vectors as recombinant viral vaccines”, by Imler, Vaccine vol. 13, No. 13, 1143-1151.
“Characterization of Australian Ovine Adenovirus Isolates”, by Boyle et al., Veterinary Microbiology, vol. 41, No. 3 (1994), pp. 281-291.
“Synthetic Vaccines”, by Nicholson, published by Blackwell Scientific Publications (Oxford, UK) pp. 346-361.
“In Vivo Adenovirus-mediated Gene Transfer to Lungs Via Pulmonary Artery”, by Lemarchand et al., Journal of Applied Physiology, vol. 76, No. 6 (1994), pp. 2840-2845.
Both Gerald Wayne
Boyle David Bernard
Vrati Sadhanshu
Commonwealth Scientific and Industrial Research Organisation
McDermott Will & Emery LLP
Priebe Scott D.
LandOfFree
DNA encoding ovine adenovirus (OAV287) and its use as a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding ovine adenovirus (OAV287) and its use as a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding ovine adenovirus (OAV287) and its use as a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3529051